News

PharmaJet receives 2017 Innovation Award in Biosciences

GOLDEN, Colo. – May 11, 2017 – PharmaJet® Inc., the maker of needle-free injection technology, announced today that it received the 2017 Innovation Award in Biosciences. The award, part of the Colorado Manufacturing Awards, recognized the company for their innovation in manufacturing and teamwork, particularly in their participation in the effort to eradicate Polio.

Polio is a crippling and potentially fatal infectious disease, mainly affecting children under five years old, and there is no cure. As part of its Global Polio Eradication Initiative (GPEI), the World Health Organization has been working closely with PATH and the Gates Foundation to clinically evaluate delivery technologies including the PharmaJet Tropis®, to accommodate in-creases in demand and vaccine supply shortages.1 Fractional dose polio vaccine delivery has been endorsed by the WHO and the Indian Ministry of Health, as it provides a more cost effective option that will enable routine immunization to more children.

“We’re right on the verge of eliminating polio from mankind,” said Ron Lowy, Chairman and Chief Executive Officer, PharmaJet Inc. “A shortage of vaccine is a big hurdle, but PharmaJet can help rectify that with its needle-free technology. We invented a device that gets the same immune responses with 60 percent less vaccine.”



Go Back